Paper1465751
Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study.
Gallacher SJ and 7 others. Thorax, 1992. Cited by 63 papers, by iCite.
Cite this record
ConductScience Library. Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study. Papers, record 1465751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1465751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Asthma | Major topic |
| Diphosphonates | Major topic |
| Osteoporosis | Major topic |
| Sarcoidosis | Major topic |
| Adult | |
| Aged | |
| Bone Density | |
| Cervical Vertebrae | |
| Female | |
| Femur | |
| Fractures, Spontaneous | |
| Humans | |
| Infusions, Intravenous | |
| Male | |
| Middle Aged | |
| Pamidronate | |
| Pilot Projects |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2109197 | Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. | N Engl J Med | 1990 | https://conductscience.org/library/papers/2109197 | PubMed |
| 2 | 1773137 | A comparison of low versus high dose pamidronate in cancer-associated hypercalcaemia. | Bone Miner | 1991 | https://conductscience.org/library/papers/1773137 | PubMed |
| 3 | 78209 | Bone disease after jejuno-ileal bypass for obesity. | Lancet | 1978 | https://conductscience.org/library/papers/78209 | PubMed |
| 4 | 1768163 | Clinical experience with pamidronate in the treatment of Paget's disease of bone. | Ann Rheum Dis | 1991 | https://conductscience.org/library/papers/1768163 | PubMed |
| 5 | 2865417 | Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia. | Lancet | 1985 | https://conductscience.org/library/papers/2865417 | PubMed |
| 6 | 4102275 | Diphosphonates and Page's disease of bone. | Lancet | 1971 | https://conductscience.org/library/papers/4102275 | PubMed |
| 7 | 6143140 | Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease. | Lancet | 1984 | https://conductscience.org/library/papers/6143140 | PubMed |
| 8 | 6616314 | Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. | Calcif Tissue Int | 1983 | https://conductscience.org/library/papers/6616314 | PubMed |
| 9 | 1859154 | A two-site immunoradiometric assay for PTH(1-84) using N and C terminal specific monoclonal antibodies. | Ann Clin Biochem | 1991 | https://conductscience.org/library/papers/1859154 | PubMed |
| 10 | 2407167 | Glucocorticoid-induced osteoporosis: pathogenesis and management. | Ann Intern Med | 1990 | https://conductscience.org/library/papers/2407167 | PubMed |
| 11 | 2567810 | Side-effects of pamidronate. | Lancet | 1989 | https://conductscience.org/library/papers/2567810 | PubMed |
| 12 | 2892989 | Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). | Lancet | 1988 | https://conductscience.org/library/papers/2892989 | PubMed |
| 13 | 3085989 | Absorption of oral diphosphonate in normal subjects. | Clin Endocrinol (Oxf) | 1986 | https://conductscience.org/library/papers/3085989 | PubMed |
| 14 | 4645238 | Routine assay of total urinary hydroxyproline based on resin-catalysed hydrolysis. | Clin Chim Acta | 1972 | https://conductscience.org/library/papers/4645238 | PubMed |
| 15 | 6298567 | Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. | Metabolism | 1983 | https://conductscience.org/library/papers/6298567 | PubMed |
| 16 | 6548074 | Circulating vitamin D metabolites and hypercalcaemia of malignancy. | Acta Endocrinol (Copenh) | 1984 | https://conductscience.org/library/papers/6548074 | PubMed |
| 17 | 6720458 | Bone histomorphometry in corticosteroid-induced osteoporosis and Cushing's syndrome. | Adv Exp Med Biol | 1984 | https://conductscience.org/library/papers/6720458 | PubMed |
| 18 | 6969728 | Effects off short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. | J Clin Endocrinol Metab | 1981 | https://conductscience.org/library/papers/6969728 | PubMed |
| 19 | 6866051 | Steroid-induced fractures and bone loss in patients with asthma. | N Engl J Med | 1983 | https://conductscience.org/library/papers/6866051 | PubMed |
| 20 | 874087 | Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose. | J Clin Invest | 1977 | https://conductscience.org/library/papers/874087 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 18415512 | [Not Available]. | Schmerz | 1995 | https://conductscience.org/library/papers/18415512 | PubMed |
| 17122953 | Advances in the management of corticosteroid-induced osteoporosis with bisphosphonates. | Clin Rheumatol | 2007 | https://conductscience.org/library/papers/17122953 | PubMed |
| 10070271 | Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind, randomised placebo controlled study. | Ann Rheum Dis | 1998 | https://conductscience.org/library/papers/10070271 | PubMed |
| 9820881 | Prevention and treatment of glucocorticoid-induced osteoporosis. | Pharm World Sci | 1998 | https://conductscience.org/library/papers/9820881 | PubMed |
| 9709383 | Osteoporosis in adults with cystic fibrosis. | J R Soc Med | 1998 | https://conductscience.org/library/papers/9709383 | PubMed |
| 9666934 | Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis. | Osteoporos Int | 1998 | https://conductscience.org/library/papers/9666934 | PubMed |
| 9638395 | Pathogenesis and treatment of glucocorticoid-induced osteoporosis. | Drugs Aging | 1998 | https://conductscience.org/library/papers/9638395 | PubMed |
| 8941496 | Corticosteroid-induced bone loss. Prevention and management. | Drug Saf | 1996 | https://conductscience.org/library/papers/8941496 | PubMed |
| 8852571 | Intravenous administration of alendronate counteracts the in vivo effects of glucocorticoids on bone remodeling. | Calcif Tissue Int | 1996 | https://conductscience.org/library/papers/8852571 | PubMed |
| 8845585 | Bisphosphonates and the treatment of bone disease in the elderly. | Drugs Aging | 1996 | https://conductscience.org/library/papers/8845585 | PubMed |
| 8706593 | Comparative clinical pharmacology and therapeutic use of bisphosphonates in metabolic bone diseases. | Drugs | 1996 | https://conductscience.org/library/papers/8706593 | PubMed |
| 7950525 | The therapeutic use of bisphosphonates. | BMJ | 1994 | https://conductscience.org/library/papers/7950525 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1465751
GET https://conductscience.org/api/papers/v1/1465751/references?page=2